Cash Flow Statement
Growth Metrics

Mimedx (MDXG) Total Non-Current Liabilities (2016 - 2026)

Mimedx's Total Non-Current Liabilities history spans 17 years, with the latest figure at $60.6 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 0.82% to $60.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $60.6 million, a 0.82% increase, with the full-year FY2025 number at $80.7 million, up 27.29% from a year prior.
  • Total Non-Current Liabilities hit $60.6 million in Q1 2026 for Mimedx, down from $80.7 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for MDXG hit a ceiling of $94.3 million in Q3 2022 and a floor of $58.3 million in Q2 2024.
  • Historically, Total Non-Current Liabilities has averaged $77.2 million across 5 years, with a median of $80.7 million in 2025.
  • Biggest five-year swings in Total Non-Current Liabilities: crashed 37.55% in 2024 and later rose 27.29% in 2025.
  • Tracing MDXG's Total Non-Current Liabilities over 5 years: stood at $92.2 million in 2022, then increased by 2.12% to $94.1 million in 2023, then crashed by 32.6% to $63.4 million in 2024, then grew by 27.29% to $80.7 million in 2025, then fell by 24.88% to $60.6 million in 2026.
  • Business Quant data shows Total Non-Current Liabilities for MDXG at $60.6 million in Q1 2026, $80.7 million in Q4 2025, and $74.5 million in Q3 2025.